BioMarin raised its outlook. It only raised one part of it
BioMarin's second quarter sent the stock up sixteen percent in three trading days. Revenue rose a fifth to $990 million, earnings beat expectations by a wide margin, and the company…
BioMarin's second quarter sent the stock up sixteen percent in three trading days. Revenue rose a fifth to $990 million, earnings beat expectations by a wide margin, and the company…
Zeta Global reported its twentieth consecutive quarter of beating its own guidance and raising it. Revenue grew 44 percent to $443 million, the company posted positive net income under US…